Showing results (181-190 of 301) with videos related to

Sort By:
Pageof 31
The American Journal of Gastroenterology|November 8, 2017
Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease PhenotypeBenjamin Click, Alyce M Anderson, Ioannis E Koutroubakis, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2006
IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expressionSally E Wenzel, Silvana Balzar, Elizabeth Ampleford, et al.
The Lancet. Respiratory Medicine|October 24, 2015
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort studyDavid B Price, Anna Rigazio, Jonathan D Campbell, et al.
The Lancet. Respiratory Medicine|October 13, 2014
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging studyMario Castro, Sally E Wenzel, Eugene R Bleecker, et al.
The Journal of Allergy and Clinical Immunology|June 1, 2011
Obesity and asthma: an association modified by age of asthma onsetFernando Holguin, Eugene R Bleecker, William W Busse, et al.
Cell Reports|April 14, 2021
High-dimensional profiling clusters asthma severity by lymphoid and non-lymphoid statusMatthew J Camiolo, Xiaoying Zhou, Timothy B Oriss, et al.
The Lancet. Respiratory Medicine|March 14, 2014
Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic studyVictor E Ortega, Gregory A Hawkins, Wendy C Moore, et al.
American Journal of Respiratory and Critical Care Medicine|February 5, 2021
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research ProgramAnnette T Hastie, David T Mauger, Loren C Denlinger, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Increased Muc5AC and Decreased Ciliated Cells in Severe Asthma Partially Restored by Inhibition of IL-4Rα ReceptorJonathan Boomer, Jiwoong Choi, Alexander Alsup, et al.
Pageof 31